Elsevier

Medical Clinics of North America

Volume 81, Issue 6, 1 November 1997, Pages 1273-1288
Medical Clinics of North America

NEPHROSCLEROSIS AND HYPERTENSION

https://doi.org/10.1016/S0025-7125(05)70582-4Get rights and content

This article reviews the involvement of the kidney as a target organ of essential hypertension. Essential hypertension has been divided into two forms: benign and malignant. The three major target organs of a patient with essential hypertension are the brain, cardiovascular system, and kidney. End-stage renal disease (ESRD) is a major public health problem, and in 1991, about 190,000 persons in the United States underwent either dialysis or a renal transplant for ESRD.31 Benign or malignant nephrosclerosis often is the term used to describe the histologic changes of the kidney associated with the benign or malignant phase of essential hypertension. In this article, gross features, light microscopic and electron microscopic findings, and glomerular hemodynamics of hypertensive experimental models with antihypertensive treatments are demonstrated.

Section snippets

BENIGN NEPHROSCLEROSIS

The term benign nephrosclerosis is often used to describe the kidney of the benign phase of essential hypertension. A patient with benign hypertension may subsequently develop malignant hypertension. Benign essential hypertension is characterized by moderate elevation of blood pressure (diastolic pressure of 90 to 120 mm Hg or occasionally higher than this), cardiac enlargement, congestive heart failure, stroke with hemorrhage and infarction, coronary artery disease, and narrowing of arteries

MALIGNANT NEPHROSCLEROSIS

Accelerated hypertension is a clinical syndrome with severe hypertension, hypertensive encephalopathy, funduscopic findings of hemorrhages and exudates, congestive heart failure, acute and progressive renal failure, and microangiopathic hemolytic anemia.6 The coexistence of papilledema defines malignant hypertension. The difference in the management of these two syndromes may depend on the degree of urgency in treating vital organ involvement rather than on the presence or absence of

HEMODYNAMIC FACTORS

In various rat models of essential hypertension, micropuncture techniques have provided valuable information as to glomerular hemodynamics. Male SHR, the genetic hypertension model bred by Aoki and Okamoto, has significantly increased afferent arteriolar resistance (RA) with mean arterial pressure (MAP) at the 17- to 20-week stage but shows no increase in glomerular hydrostatic pressure (PG), efferent arteriolar resistance (RE), and glomerular plasma flow rate (QA).1 This strain also exhibits

SUMMARY

In patients with benign nephrosclerosis, the histologic changes are characterized by hyaline degeneration of afferent arterioles with reduced kidney size. Although the glomeruli are nearly intact in patients with adult essential hypertension, the greatest numbers of sclerotic glomeruli are seen in nephrosclerosis with the aging process.20 Aging undoubtedly plays a role. In the authors' experience, the kidney of an elderly subject, although with normotensive pressure and normal level of

References (37)

  • L.D. Dworkin et al.

    Hemodynamic basis for glomerular injury in rats with deoxycorticosterone-salt hypertension

    J Clin Invest

    (1984)
  • E.R. Fisher et al.

    Ultrastructural studies in hypertension: I. Comparison of renal vascular and juxtamedullary cell alterations in essential and renal hypertension in man

    Lab Invest

    (1966)
  • N. Gibbons et al.

    Glomerular hypertension (GH) enhances mesangial cell apoptosis: An in vivo study

    J Am Soc Nephrol

    (1996)
  • P.J. Goldblatt et al.

    Benign and malignant nephrosclerosis and renovascular hypertension

  • K.E. Grund et al.

    Renal insufficiency in nephrosclerosis (benign nephrosclerosis resp. transition from benign to secondary malignant nephrosclerosis): Correlations between morphological and functional parameters

    Klin Wochenschr

    (1978)
  • T. Gudbrandsson et al.

    Malignant hypertension: Improving prognosis in a rare disease

    Acta Med Scand

    (1979)
  • U. Helmchen et al.

    Role of the renin-angiotensin system in renal hypertension: An experimental approach

    Curr Top Pathol

    (1976)
  • R.H. Heptinstall

    Malignant hypertension: A study of fifty-one cases

    J Pathol Bacteriol

    (1953)
  • Cited by (29)

    • Nonneoplastic Diseases of the Kidney

      2020, Urologic Surgical Pathology
    • Aerobic exercise training prevents kidney lipid deposition in mice fed a cafeteria diet

      2018, Life Sciences
      Citation Excerpt :

      These changes can lead to glomerular injury, glomerulosclerosis, irregular tubular atrophy and fibrosis. Usually, hyalilized glomeruli are smaller than the normal due to the loss of cellular elements [24,28]. Although some studies have shown that a hyperlipidic or hypercaloric diet may cause renal morphological alterations [4,10], these results are not well established in the literature.

    • Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-Β1 promoter

      2011, Kidney International
      Citation Excerpt :

      The multiple reaction monitoring transition for polyamide 2 was m/z 834>165. After 3-μm paraffin sections were stained with periodic acid-Schiff reagent or Masson's trichrome stain for semiquantitative evaluation, glomerular injury score, and tubulointerstitial injury score were determined as described previously.41,42 Total RNA was extracted from renal cortex by using RNEasy Mini kit (Qiagen, Valencia, CA, USA).

    • Non-neoplastic diseases of the kidney

      2008, Urologic Surgical Pathology: Second Edition
    • Non-neoplastic Diseases of the Kidney

      2006, Genitourinary Pathology
    • Green iguana nephrology: A review of diagnostic techniques

      2003, Veterinary Clinics of North America - Exotic Animal Practice
    View all citing articles on Scopus

    Address reprint requests to, Hidehiko Ono, MD, Division of Hypertension and Cardiorenal Disease, Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gunn, Tochigi 321-02, Japan

    *

    Division of Hypertension and Cardiorenal Disease, Department of Internal Medicine (HO), and the Department of Pathology (YO), Dokkyo University School of Medicine, Tochigi, Japan

    View full text